Series C - Oviva

Series C - Oviva

Investment Firm

Overview

Oviva offers digital solutions for treating diabetes and obesity using a platform focused on behavior change.

Announced Date

Aug 31, 2021

Funding Type

Series C

Highlights

Location

Switzerland, Europe

Social

Investor Lead

Temasek Holdings

Temasek Holdings

Temasek Holdings is a early_stage_venture and late_stage_venture and private_equity and secondary_market firm.

Sofina

Sofina

Sofina is a debt and early_stage_venture and late_stage_venture and private_equity and seed and venture firm.

Participant Investors

7

Investor Name
Participant InvestorTemasek Holdings
Participant InvestorF-Prime Capital
Participant InvestorAlbionVC
Participant InvestorEight Roads Ventures
Participant InvestorEarlybird Venture Capital

Round Details and Background

Oviva raised $80000000 on 2021-08-31 in Series C

Oviva offers digital solutions for treating diabetes and obesity using a platform focused on behavior change.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 01, 2016
Venture Round - Oviva
1-undefined
Jan 15, 2020
Series B - Oviva
6-21.0M
Aug 31, 2021
Series C - Oviva
7-80.0M
Sep 14, 2016
Non Equity Assistance - Oviva
1-undefined

Recent Activity

There is no recent news or activity for this profile.